Department of Otolaryngology-Head & Neck Surgery, University of California San Diego, San Diego.
Department of Neurological Surgery, University of California San Diego, San Diego.
JAMA Otolaryngol Head Neck Surg. 2023 Apr 1;149(4):352-358. doi: 10.1001/jamaoto.2022.5243.
High surgical vestibular schwannoma case volume in a medical institution may decrease the risk of adverse outcomes among patients undergoing vestibular schwannoma surgery.
To study the association between surgical vestibular schwannoma case volume and excess time in the hospital after vestibular schwannoma surgery.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study evaluated data from the National Cancer Database from January 1, 2004, through December 31, 2019, on Commission on Cancer-accredited facilities in the US. The hospital-based sample comprised adult patients aged 18 years or older with a vestibular schwannoma treated with surgery.
Facility case volume, defined as the mean number of surgical vestibular schwannoma cases per year in the 2 years preceding the index case.
The primary outcome was a composite of prolonged hospital stay (>90th percentile) or 30-day readmission. Risk-adjusted restricted cubic splines were used to model the probability of the outcome according to facility volume. The inflection point (in cases per year) when the declining risk of excess time in the hospital began to plateau was selected as the threshold to define high- and low-volume facilities. Outcomes were compared among patients treated at high- and low-volume facilities, with mixed-effects logistic regression models adjusting for patient sociodemographic characteristics, comorbidities, tumor size, and clustering within facilities. Collected data were analyzed between June 24 and August 31, 2022.
Among 11 524 eligible patients (mean [SD] age, 50.2 [12.8] years; 53.5% female; 46.5% male) who underwent surgical resection of vestibular schwannoma at 66 reporting facilities, the median length of stay was 4 (IQR, 3-5) days, and 655 patients (5.7%) were readmitted within 30 days. The median case volume was 16 (IQR, 9-26) cases per year. An adjusted restricted cubic spline model identified a downtrending probability of excess time in the hospital with increasing volume. The declining risk of excess time in the hospital began to plateau at a facility volume of 25 cases per year. Surgery at a facility with an annual case volume at or above this threshold was independently associated with a 42% reduction in the odds of excess time in the hospital compared with surgery at a low-volume center (odds ratio, 0.58; 95% CI, 0.44-0.77).
This cohort study found that among adults undergoing vestibular schwannoma surgery, a higher facility case volume was associated with a reduced risk of prolonged hospital stay or 30-day readmission. A facility case volume of 25 cases per year may represent a risk-defining threshold.
医疗机构中高手术前庭神经鞘瘤病例量可能会降低接受前庭神经鞘瘤手术患者的不良结局风险。
研究手术前庭神经鞘瘤病例量与前庭神经鞘瘤手术后住院时间延长之间的关联。
设计、设置和参与者:这项队列研究评估了美国癌症委员会认证机构 2004 年 1 月 1 日至 2019 年 12 月 31 日期间国家癌症数据库中的数据。基于医院的样本包括在接受手术治疗的前庭神经鞘瘤的 18 岁或以上的成年患者。
设施病例量,定义为索引病例前两年中每年手术前庭神经鞘瘤病例的平均值。
主要结果是住院时间延长(>第 90 百分位数)或 30 天内再入院的复合结果。使用风险调整的限制立方样条模型根据设施数量来预测结果的概率。当住院时间延长风险开始趋于平稳的下降拐点(每年病例数)被选为定义高容量和低容量设施的阈值。通过混合效应逻辑回归模型调整患者社会人口统计学特征、合并症、肿瘤大小和设施内聚类,比较高容量和低容量设施治疗患者的结果。收集的数据于 2022 年 6 月 24 日至 8 月 31 日之间进行分析。
在 66 家报告机构接受手术切除前庭神经鞘瘤的 11524 名合格患者中(平均[SD]年龄,50.2[12.8]岁;53.5%女性;46.5%男性),中位住院时间为 4(IQR,3-5)天,655 名患者(5.7%)在 30 天内再次入院。中位病例量为 16(IQR,9-26)例/年。调整后的限制立方样条模型确定了住院时间延长的概率随着病例量的增加而呈下降趋势。住院时间延长风险的下降趋势在每年 25 例的设施量开始趋于平稳。与低容量中心相比,在每年病例量达到或超过该阈值的机构进行手术与住院时间延长的几率降低 42%相关(比值比,0.58;95%CI,0.44-0.77)。
这项队列研究发现,在接受前庭神经鞘瘤手术的成年人中,较高的机构病例量与降低住院时间延长或 30 天内再入院的风险相关。每年 25 例的机构病例量可能代表风险定义的阈值。